How COVID-19 Affected Newly Discovered Cases of COPD in Three Industrial Regions of Kazakhstan

Abstract

A.N. Zhamakurova, S.S. Salimova, L.R. Idrissova and Essetova G.U

Introduction: In the coming decades, COPD will take the 5th place among the leading causes of disability and already ranks 3rd among the causes of death. Approximately 384 million people worldwide suffer from chronic obstructive pulmonary disease (COPD), and it is estimated that more than half of patients with COPD may be undiagnosed.

Aim: To investigate the prevalence of chronic obstructive pulmonary disease in Kazakhstan and if COPD-19 affected detection of new cases of COPD in industrial regions of Kazakhstan.

Materials and Methods: A comparative retrospective analysis of the incidence of COPD in the context of the regions of the Republic of Kazakhstan for 2013-2022 was carried out according to the statistical collections "Health of the population of the Republic of Kazakhstan and the activities of healthcare organizations”.

Results: Over the past 10 years in the Republic of Kazakhstan, there has been a decline in COPD prevalence. High prevalence was observed in 2016, with 386.2 cases per 100,000 population. The growth rate in 2022 was 80.62% compared to 2002. COPD prevalence per 100,000 population, broken down by regions, is highest in the Almaty region (502.8) and in the city of Almaty (440.4). The lowest rate was recorded in the Mangystau (104.3) and West Kazakhstan (106.5) regions.

Conclusion: Thus, in Kazakhstan, during the study period (2013-2022), there was a decrease in the incidence of COPD in dynamics. Despite the decrease in morbidity in the regions of southern Kazakhstan, there is a high incidence of COPD in this part of the country compared to northern and western Kazakhstan.

PDF